Andrew Bowden
Chief Executive Officer
Replay available
Item 9 Labs Corp (OTC: INLB) Q4 2021 earnings conference call, held 2022-01-18. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Chief Financial Officer
Chief Franchise Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Item 9 Labs Corp..
WEBVTT 00:00:00.109 -- 00:00:03.332 All right. Good afternoon, everyone, or good morning, depending on where you're calling 00:00:03.332 -- 00:00:09.257 in from. Appreciate you joining us today. Today is January 00:00:09.257 -- 00:00:10.879 18th, 2022. 00:00:10.879 -- 00:00:15.202 Thank you for joining us again. So this is item nine labs core fiscal 00:00:15.202 -- 00:00:21.856 year 2021 annual results conference call for the 12 months ended September 30th, 2021. 00:00:21.988 -- 00:00:26.547 By now, everyone should have had access to the earnings results press release. 00:00:26.547 -- 00:00:30.289 which was issued earlier today before the markets opened around 9 a.m. 00:00:30.289 -- 00:00:36.432 Eastern time. This call is being webcast and will be available for replay. 00:00:36.673 -- 00:00:40.775 In our remarks today, we will include statements that are considered forward-looking 00:00:40.775 -- 00:00:45.398 within the meanings of securities laws, including forward-looking statements about future 00:00:45.398 -- 00:00:50.921 results of operations, business strategies and plans, our relationships with our customers, 00:00:50.921 -- 00:00:53.723 market and potential growth opportunities. 00:00:53.723 -- 00:00:57.626 In addition, management may make additional forward-looking statements in response to 00:00:57.626 -- 00:01:02.207 your questions. Forward-looking statements are based on management's current knowledge 00:01:02.207 -- 00:01:07.209 and expectations as of today and are subject to certain risks and uncertainties and may 00:01:07.209 -- 00:01:12.270 cause the actual results to differ materially from the forward-looking statements. 00:01:12.270 -- 00:01:16.252 A detailed discussion of such risks and uncertainties are contained in our most recent 00:01:16.252 --...